Sort
64,565 grants matching “drug discovery”
Cell density effects on therapeutic sensitivity
$611,961Jayne Stommel · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Development of P2Y Receptor Ligands
$611,928Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Phase 2 Proof-of-Concept Efficacy of BT-11 in Crohn's Disease Patients
$611,918Simon Lichtiger · Landos Biopharma, Inc. · R01 · FY2020 · DK
Tuberculosis epidemiology and novel transmission routes in rural Tanzania
$611,879Philip C Hopewell · University Of California, San Francisco · U01 · FY2011 · AI
Biomarkers of Insufficient Sleep and Sleepiness
$611,872Kenneth P Wright · University Of Colorado · R01 · FY2016 · HL
Patterning myocardial specification of human pluripotent stem cells
$611,869Hee Cheol Cho · Emory University · R01 · FY2020 · HL
Patterning myocardial specification of human pluripotent stem cells
$611,869Hee Cheol Cho · Emory University · R01 · FY2021 · HL
Technology Development for 3D Electron Microscopy
$611,814Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Biochemistry of Protein Prenylation
$611,813Michael H Gelb · University Of Washington · R01 · FY2012 · AI
Optimization of glucocorticoid receptor (GR) passive antagonists for the treatment of post-traumatic stress disorder (PTSD)
$611,804Anthony Bruce Pinkerton · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · MH
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
$611,800Binghui Shen · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA
Structure-based Optimization of T. brucei methionyl tRNA Synthetase Inhibitors
$611,718Erkang Fan · University Of Washington · R01 · FY2015 · AI
Development and validation of a high-throughput MicroED-driven platform technology for natural product discovery
$611,693Cassandra Leah Quave · Emory University · R01 · FY2024 · AT
Selective inhibitors of ubiquitin E3 ligase to treat high cholesterol
$611,663David E Sterner · Progenra, Inc. · R44 · FY2014 · ES
Selective inhibitors of ubiquitin E3 ligase to treat high cholesterol
$611,663David E Sterner · Progenra, Inc. · R44 · FY2015 · ES
The multiple antibiotic resistance (Mar) regulon
$611,653Stuart B. Levy · Tufts University Boston · R01 · FY2008 · AI
Overcoming Therapy Resistance in Hedgehog Pathway-Driven Medulloblastoma
$611,591Rodney A. Stewart · Utah State Higher Education System--University Of Utah · R01 · FY2025 · NS
Sorted libraries of error-free long oligonucleotides
$611,577Jean-Marie Rouillard · Biodiscovery, Llc · R44 · FY2013 · GM
Genetic and Functional Analysis of Rapid Renal Decline in Diabetes: A Family-based Approach to Accelerate Gene Discovery
$611,553Marcus Guy Pezzolesi · University Of Utah · R01 · FY2024 · DK
Exploration of Low-Cost Long Timescale Free Energy Perturbations on FPGAs
$611,480Brian Woody Sherman · Silicon Therapeutics · R44 · FY2019 · GM
Inhibitors of disease-promoting activities of senescence
$611,473Donald C. Porter · Senex Biotechnology, Inc. · R44 · FY2008 · CA
Computer Model of the Canine Ventricle
$611,429Robert F Gilmour · Cornell University · R01 · FY2007 · HL
Structure-based Optimization of T. brucei methionyl tRNA Synthetase Inhibitors
$611,388Erkang Fan · University Of Washington · R01 · FY2012 · AI
CAREER:Engineering Brain-region-specific Organoids Derived from Human Stem Cells
$611,340Yan Li · Florida State University · · FY2017 · ENG
Molecular Classification of Anaplastic Large Cell Lymphoma
$611,311Andrew Lewis Feldman · Mayo Clinic Arizona · P01 · FY2018 · CA